Anzeige
Mehr »
Login
Montag, 25.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Microsofts, Googles und Amazons nukleares Wettrennen macht diese Uranaktie zu einem Muss!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
115 Leser
Artikel bewerten:
(0)

Cynerio, Inc.: Barts Health Implements Cynerio's Healthcare Cybersecurity Platform

Finanznachrichten News

LONDON, Nov. 12, 2024 /PRNewswire/ -- Barts Health NHS Trust has selected Cynerio's healthcare-focused platform for deployment across all sites. After thorough evaluation, the selection was made due to a combination of factors including industry-specific focus, proven proactive security measures, and cutting edge reactive measures that aid in the immediate prevention of attacks.


Cynerio's platform is designed to provide healthcare providers with deepened defences against the multitude of attacks presented by hackers. These defences are centred upon secure detection and analysis of network traffic resulting in full visibility and security analysis of connected devices including Internet of Things (IoT), Internet of Medical Things (IoMT), information technology and mobile devices. This approach enables strategic adoption of proven approaches commonly missing from healthcare environments including day-one attack detection, microsegmentation, proactive patching and clear guidance for healthcare staff. With widespread adoption, Barts Health hopes to minimise common risks faced by healthcare providers, including data breaches, ransomware incidents and other malicious attacks.

To best serve their community, Barts Health has opted to implement Cynerio's full suite, including Network Detection and Response for Healthcare (NDR-H) technology designed to monitor network traffic and detect and respond to threats. Cynerio's NDR-H sits within the hospital's network and monitors traffic without interfering with traffic flow, identifying unusual traffic, performing analysis, and alerting team members to potential attacks that could impact their ability to provide care.

"The ease that we have been able to deploy Cynerio at our 2 primary data centres and start getting Day one value has been amazing and is quickly becoming a valuable tool in our cyber security tooling," stated Ian Lyon from Barts Health.

The joint commitment of Barts Health and Cynerio has resulted in expedited adoption of new protections. Within one month, Cynerio has identified more than 9,5000 previously unmonitored devices. These devices are now monitored, analysed and secured in real-time by Barts Health staff working in conjunction with the Cynerio Customer Success team.

Darrell Bailey, Head of Sales at Cynerio highlighted the immediate value of Network Detection and Response adoption: "Cynerio's advanced technology is especially timely in light of the recent cyber attacks in Southeast London. With NDR-H, Barts Health can proactively shield itself from similar threats and the damaging effects that have impacted the healthcare sector. I'd also like to extend my gratitude to ITHealth, whose outstanding partnership made this deployment possible."

As adoption of Cynerio's offerings matures, Barts Health will continue to see greater benefits including deeper insight into network risk; discovery of potential vulnerabilities within network infrastructure; actionable remediation guidance; one-click reporting and customised dashboards; and complete asset visibility of all connected devices. The Cynerio platform will also enable enhancement of Medical Engineer efficiency by identifying device location, facilitating prompt response and ensuring optimal utilisation of resources.

About Cynerio:

Cynerio's Healthcare Cybersecurity Platform is tailored to safeguard medical environments against constantly evolving threats. From real-time detection of malicious network activity to strategic micro-segmentation guidance, Cynerio delivers a suite of proactive and reactive protections that elevate the security of healthcare facilities and ensure the safety of patients. For more information visit, www.cynerio.com.

Media Contact:
Name: Vicki Michaeli
Email: vicki@cynerio.com

Logo - https://mma.prnewswire.com/media/1876294/Cynerio_Logo_Logov1.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/barts-health-implements-cynerios-healthcare-cybersecurity-platform-302301470.html

© 2024 PR Newswire
Nach Nvidia: 5 KI-Revolutionäre aus der zweiten Reihe!
Künstliche Intelligenz hat spätestens nach dem Raketenstart von Chat GPT das Leben aller verändert. Doch der Superzyklus steht nach Meinungen von Experten erst am Anfang. Während Aktien wie Nvidia von der ersten Aufwärtsentwicklung stark profitieren konnten, versprechen aussichtsreiche Player aus der

zweiten Reihe noch enormes Aufwärtspotenzial.

Im kostenlosen, exklusiven Spezialreport präsentieren wir ihnen 5 innovative KI-Unternehmen, die bahnbrechende Entwicklungen in diesem Sektor prägen könnten.

Warum sollten Sie dabei sein?
Trotz der jüngsten Erfolge steht die Entwicklung der künstlichen Intelligenz noch am Beginn eines neuen Superzyklus. Experten gehen davon aus, dass der Sektor bis 2032 global auf 1,3 Billionen US-Dollar explodieren wird, wobei ein großer Teil auf Hardware und Infrastruktur entfallen wird.

Nutzen Sie die Chance!
Fordern Sie sofort unseren brandneuen Spezialreport an und erfahren Sie, welche 5 KI-Aktien das größte Potenzial zur Vervielfachung besitzen. Dieser Report ist komplett kostenlos und zeigt Ihnen die aussichtsreichsten Investments im KI-Sektor.
Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.